| Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report P Malfertheiner, F Megraud, T Rokkas, JP Gisbert, JM Liou, C Schulz, ... Gut 71 (9), 1724-1762, 2022 | 659 | 2022 |
| Asia–Pacific consensus guidelines on gastric cancer prevention KM Fock, N Talley, P Moayyedi, R Hunt, T Azuma, K Sugano, SD Xiao, ... Journal of gastroenterology and hepatology 23 (3), 351-365, 2008 | 487 | 2008 |
| Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease CH Lin, CC Chen, HL Chiang, JM Liou, CM Chang, TP Lu, EY Chuang, ... Journal of neuroinflammation 16, 1-9, 2019 | 358 | 2019 |
| Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial JM Liou, CC Chen, MJ Chen, CC Chen, CY Chang, YJ Fang, JY Lee, ... The Lancet 381 (9862), 205-213, 2013 | 334 | 2013 |
| Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus JM Liou, P Malfertheiner, YC Lee, BS Sheu, K Sugano, HC Cheng, ... Gut 69 (12), 2093-2112, 2020 | 320 | 2020 |
| Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis YT Kuo, JM Liou, EM El-Omar, JY Wu, AHR Leow, KL Goh, R Das, H Lu, ... The Lancet Gastroenterology & Hepatology 2 (10), 707-715, 2017 | 271 | 2017 |
| Helicobacter pylori infection P Malfertheiner, MC Camargo, E El-Omar, JM Liou, R Peek, C Schulz, ... Nature reviews Disease primers 9 (1), 19, 2023 | 241 | 2023 |
| Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial JM Liou, CC Chen, CM Chang, YJ Fang, MJ Bair, PY Chen, CY Chang, ... The Lancet Infectious Diseases 19 (10), 1109-1120, 2019 | 161 | 2019 |
| Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial JM Liou, YJ Fang, CC Chen, MJ Bair, CY Chang, YC Lee, MJ Chen, ... The Lancet 388 (10058), 2355-2365, 2016 | 151 | 2016 |
| Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with … JM Liou, JT Lin, CY Chang, MJ Chen, TY Cheng, YC Lee, CC Chen, ... Gut 59 (5), 572-578, 2010 | 150 | 2010 |
| Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease SJ Chen, CC Chen, HY Liao, YT Lin, YW Wu, JM Liou, MS Wu, CH Kuo, ... Neurology 98 (8), e848-e858, 2022 | 129 | 2022 |
| The interplay between Helicobacter pylori and gastrointestinal microbiota CC Chen, JM Liou, YC Lee, TC Hong, EM El-Omar, MS Wu Gut microbes 13 (1), 1909459, 2021 | 122 | 2021 |
| Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria YJ Fang, JM Liou, CC Chen, JY Lee, YC Hsu, MJ Chen, PH Tseng, ... Gut 64 (10), 1517-1528, 2015 | 113 | 2015 |
| Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial JM Liou, CC Chen, CY Chang, MJ Chen, YJ Fang, JY Lee, CC Chen, ... Journal of Antimicrobial Chemotherapy 68 (2), 450-456, 2013 | 107 | 2013 |
| Delayed endoscopy as a risk factor for in‐hospital mortality in cirrhotic patients with acute variceal hemorrhage YC Hsu, CS Chung, CH Tseng, TL Lin, JM Liou, MS Wu, FC Hu, HP Wang Journal of gastroenterology and hepatology 24 (7), 1294-1299, 2009 | 106 | 2009 |
| Plasma insulin-like growth factor-binding protein-2 levels as diagnostic and prognostic biomarker of colorectal cancer JM Liou, CT Shun, JT Liang, HM Chiu, MJ Chen, CC Chen, HP Wang, ... The Journal of Clinical Endocrinology & Metabolism 95 (4), 1717-1725, 2010 | 97 | 2010 |
| Psychopathology and personality trait in subgroups of functional dyspepsia based on Rome III criteria YC Hsu, JM Liou, SC Liao, TH Yang, HT Wu, WL Hsu, HJ Lin, HP Wang, ... Official journal of the American College of Gastroenterology| ACG 104 (10 …, 2009 | 94 | 2009 |
| The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors—A … JM Liou, CY Chang, MJ Chen, CC Chen, YJ Fang, JY Lee, JY Wu, JC Luo, ... PLoS One 10 (5), e0124199, 2015 | 91 | 2015 |
| Genotypic Resistance in Helicobacter pylori Strains Correlates with Susceptibility Test and Treatment Outcomes after Levofloxacin- and Clarithromycin-Based … JM Liou, CY Chang, WH Sheng, YC Wang, MJ Chen, YC Lee, HW Hung, ... Antimicrobial agents and chemotherapy 55 (3), 1123-1129, 2011 | 82 | 2011 |
| Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial JM Liou, CC Chen, CY Chang, MJ Chen, CC Chen, YJ Fang, JY Lee, ... Gut 65 (11), 1784-1792, 2016 | 81 | 2016 |
